Skip to main content

Affiliate disclosure: We may earn a commission if you buy through links on this site — at no extra cost to you. Thanks!

Telehealth Doctor for Medicare GLP-1 Bridge: Who Can Submit the $50 Prior Authorization?

Last verified: ·By WPG Research Team

Looking for a telehealth doctor for Medicare GLP-1 Bridge coverage? Short answer: yes, a telehealth doctor can help — but only if they can do four things. They have to be licensed to treat you in your state, willing to prescribe a Bridge-covered medication, able to submit the Bridge prior authorization to Medicare's central processor, and not on Medicare's Preclusion List. The doctor does not have to "accept Medicare" for the medication to be covered. The catch most pages skip: CMS won't process any Bridge request before July 1, 2026, the copay is $50 a month, and the Bridge does not cover compounded semaglutide or tirzepatide, or Ozempic and Mounjaro used for diabetes.

So if you've been drowning in policy pages that explain the program but never tell you who actually writes the prescription — this is the page that answers it. We'll show you exactly who can submit the request, whether you likely qualify, which drugs are in, and the short list of questions to ask before you pay any clinic a dollar.

We are Weight Loss Provider Guide, an independent comparison resource for GLP-1 telehealth providers. We are not Medicare, not CMS, and not a medical practice, and this page is information, not medical advice. We pulled the facts below from CMS, KFF, and the FDA, and we label anything that's a provider's own claim rather than a verified fact. Last verified: May 28, 2026. This page contains affiliate links; if you start care through some providers we mention, we may earn a commission at no extra cost to you — and we tell you plainly where a free or non-affiliate path is the better move.

Get your Bridge doctor game plan (free, 60 seconds)

Not sure which path fits you — your own doctor, a telehealth visit, or standard Part D? Take our free 60-second matching quiz and get your likely route, the records to gather, and the questions to ask, before you book anything. (Self-screening only — please don't enter your Medicare ID number or personal health details.)

Take our free 60-second matching quiz →

What we actually verified (and what's still pending)

We split this page into two buckets on purpose, because most pages mix solid government rules with provider marketing and you can't tell which is which.

Confirmed from CMS, KFF, and the FDA

  • The Bridge runs July 1, 2026 through December 31, 2027. (CMS, KFF)
  • It runs outside your normal Part D benefit, through a CMS central processor — not your plan or its pharmacy benefit manager.
  • A medical provider must submit the prior authorization and the prescription.
  • The provider does not need to be enrolled in Medicare, but must not be on the CMS Preclusion List.
  • Covered drugs and the $50 copay (manufacturers supply at a $245 net monthly price). (KFF)
  • CMS has named the central processor and published pharmacy billing basics (BIN 028918 / PCN MEDDGLP1BR).

Still pending or provider-specific

  • The full payer sheet and step-by-step prescriber instructions are still forthcoming from CMS.
  • We have not independently verified any provider's live Bridge submission workflow, because the program hasn't opened yet. Some clinics publish Bridge-specific claims — treat those as provider-stated, not independently verified.

That second bucket is the whole reason this page exists. Let's get into it.

Can a telehealth doctor submit the Medicare GLP-1 Bridge prior authorization?

Yes. CMS says a medical provider must submit the Bridge prior authorization (the paperwork that proves you qualify) along with the prescription. CMS doesn't single out telehealth — but a telehealth clinician fits that definition just fine, as long as they're licensed to treat you, willing to submit the Bridge PA, and not on the Medicare Preclusion List. And the provider does not have to be enrolled in Medicare for the medication to be covered. That one rule is what unlocks this whole thing.

Here's the part people get tangled in. "Accepting Medicare" and "submitting a Bridge PA" are not the same step:

  1. 1
    Treating you legally in your state.Telehealth licensing is state by state. A doctor has to be licensed where you are.
  2. 2
    Prescribing a Bridge-covered drugWegovy, Zepbound (KwikPen), or Foundayo. (Exact list below.)
  3. 3
    Submitting the Bridge PATo the CMS central processor, attesting you meet the criteria.
  4. 4
    Documenting that you qualifyYour BMI at the time you started GLP-1 therapy, plus any qualifying condition.

A doctor can do all four whether or not they "take Medicare" for the office visit. Accepting Medicare affects whether your visit is covered. It does not affect whether the drug is covered through the Bridge.

A word that protects you

A real telehealth visit for these drugs is real medical care — history, weight history, a contraindication check, side-effect counseling, a follow-up plan. If a clinic treats it like a vending machine where you pay and a script pops out, that's a flag, not a feature.

Use our free checklist before you book

Make sure the clinic can actually submit the Bridge PA — not just hand you a prescription or a normal commercial-insurance PA.

The 7 questions to ask any telehealth doctor before you pay

The single most expensive mistake

Before you pay for a visit, confirm the clinic can do the Bridge-specific work — not just prescribe a GLP-1. Paying a cash-pay clinic that writes you a compounded prescription the Bridge will never cover is the costliest error here. Copy these questions and ask them on the intake call, chat, or email. If a clinic can't answer them clearly, that's your answer.

We built this list from the CMS provider rules, so each question maps to something the Bridge actually requires.

  1. 1

    "Are your clinicians licensed to treat patients in my state?"

  2. 2

    "Will your clinician submit the CMS Medicare GLP-1 Bridge prior authorization — not just a regular insurance PA?"← If you only ask one, ask this one.

  3. 3

    "Will you submit Bridge PAs on or after July 1, 2026?" (Nothing can be processed before then.)

  4. 4

    "Do you prescribe Wegovy, Zepbound KwikPen, or Foundayo?" (These are the covered ones.)

  5. 5

    "How do you document my BMI at the time I started GLP-1 therapy?"

  6. 6

    "Can you use records from my prior doctor or telehealth provider?"

  7. 7

    "What are the visit costs, and what's my refund if you can't submit a Bridge PA?"

A lot of weight-loss clinics are great at prescribing and terrible at government paperwork. You want both.

Take the questions with you

How to choose a telehealth doctor for Medicare GLP-1 Bridge

Start with your own doctor if…

They already have your weight history and they're willing to do the Bridge paperwork. Switch to a telehealth doctor when your regular doctor refuses to prescribe weight-loss medication, doesn't handle prior authorizations, or can't see you before the program opens. For most people, the cheapest and fastest path is the doctor who already knows them.

Our one honest catch — we'd rather you hear it from us

A telehealth clinic is not automatically your best move. If your current doctor already has your BMI history and your records and will submit the Bridge PA, they're usually the better starting point — it's cheaper, and the documentation is already in your chart. Telehealth shines when your doctor says "we don't prescribe those," when they don't do obesity-medication paperwork, or when their next opening is months out. So if a telehealth provider's marketing makes it sound like they're the only way in, that's not true.

Here's how to pick

Your situationBest first moveWhy
Your doctor already prescribed or monitored your GLP-1Your current doctorYour starting-BMI and diagnosis records are likely already in your chart
Your doctor refuses weight-loss meds or won't do the paperworkObesity-medicine telehealthThese clinics live in this workflow daily
You used a compounded telehealth providerAsk them for your records, then verify Bridge supportYou need the documentation; many compounded programs won't touch the Bridge
You need Ozempic/Mounjaro for diabetesStandard Part DThat may be a covered Part D use, not the Bridge
You only want compounded semaglutide/tirzepatideThe Bridge is not your programIt only covers specific FDA-approved brands

The doctor pathway matrix

This is the table we wish existed when we started digging. It compares the real doctor paths by the one thing that actually matters here — can this path solve the Bridge problem? — not by who pays us. For every clinic, we label whether Bridge support is independently verified, provider-stated, or not verified, because right now that difference is everything.

Doctor pathCan it submit the Bridge PA?Bridge PA supportBest forConfirm before you pay
Your own PCP / obesity-medicine doctorYes, if willing & not on the Preclusion ListDepends on the doctorPeople whose doctor already has their records"Will you submit the Bridge PA after July 1?"
Local endocrinology / obesity clinicYes, if willingDepends on the clinicComplex conditions or past denials"Do you handle Medicare anti-obesity PAs?"
Form HealthLikely, if they offer itProvider-stated Medicare acceptance; Bridge PA not verifiedStructured obesity-medicine telehealth"Will you submit the Bridge PA specifically?"
knownwellLikely, if they offer itProvider-stated Medicare acceptance; Bridge PA not verifiedAll-50-states virtual weight care"Do you submit Medicare GLP-1 Bridge PAs?"
ShapelyPossibly, state-limitedProvider-stated Medicare in CA/FL/NY/TX; Bridge PA not verifiedPeople in those four states"Are you licensed in my state, and do you support the Bridge PA?"
MochiProvider claims yesProvider-stated; not independently verifiedPeople weighing a clinic that publicly discusses the Bridge"Confirm the dates and that you submit to the CMS central processor"
Midwest Mind & BodyProvider claims yes (16 states)Provider-stated; not independently verifiedPeople in its listed states"Do you serve my state and submit after July 1?"
RoNot for the BridgeRo says it currently can't coordinate GLP-1 coverage for government insurance plansA non-Medicare / cash-pay brand option(Not a Bridge path)
SesameNot verified for the BridgeTreat as cash-pay / commercial unless they confirm itProvider-choice cash shoppers"Do you support the CMS Bridge PA?"
Pharmacy or your Part D plan aloneNo — they can't prescribeNot a doctor pathFilling the script after approval"Can you process the Bridge claim?"

Verification note: Provider Medicare statements above are each company's own claim unless marked independently verified. "Not verified" means we have not confirmed a live Bridge-specific PA workflow — none exists publicly until the program opens. Re-verified May 28, 2026.

How to read this: the winner for most readers isn't a brand — it's "a willing prescriber who'll do the Bridge paperwork." Sometimes that's your own doctor. Sometimes it's a telehealth clinic. This table is here so you stop guessing and start asking the right clinic the right questions.

Find the doctor path that fits you

Answer a few quick questions and we'll point you to the right starting line — your PCP, obesity-medicine telehealth, or standard Part D.

Do you qualify for the Medicare GLP-1 Bridge?

You may qualify if you're at least 18, enrolled in an eligible Medicare Part D plan, your GLP-1 is prescribed for weight reduction or maintenance alongside ongoing lifestyle changes, and your BMI at the time you started GLP-1 therapy meets one of CMS's three pathways. The detail that trips people up: CMS looks at your BMI when you started the medication — not your BMI today.

A PDP is a standalone Part D prescription drug plan. An MA-PD is a Medicare Advantage plan that includes drug coverage. You need an eligible one of those. Here are the three eligibility lanes as CMS has laid them out.

LaneBMI when you started therapyPlus this, if BMI is under 35
Lane 135 or higherNothing else needed
Lane 230 or higherHeart failure with preserved ejection fraction (HFpEF), uncontrolled high blood pressure (top number over 140 or bottom over 90 on two BP meds), or chronic kidney disease stage 3a or worse
Lane 327 or higherPrediabetes, a past heart attack, a past stroke, or symptomatic peripheral artery disease (reduced blood flow in the limbs)

On top of a lane, the medication has to be prescribed for weight reduction or maintenance, along with ongoing lifestyle changes (nutrition and activity), consistent with the FDA-approved label. (CMS, KFF)

"My BMI dropped — did I just lose my spot?"

No, and this is great news for anyone who's already made progress. CMS judges your BMI at the moment you started GLP-1 therapy. CMS's own example: someone who began treatment at a BMI of 37 and is now at 34 can still qualify, because they met the BMI-35 line when they started. (CMS) So dig up your starting numbers — old chart notes, the first prescription, pharmacy receipts, the visit where you got your diagnosis.

Records to bring, by lane

Use this to walk into your visit ready. The more complete this is, the faster a doctor can submit.

Your laneRecords to gather
Lane 1 — BMI 35+Proof of your weight and height from when you started the GLP-1 (the visit note, first prescription, or pharmacy record)
Lane 2 — BMI 30+ with a conditionYour starting weight/height plus the diagnosis and labs for HFpEF, your blood-pressure readings and the two BP medicines you take, or your kidney labs (eGFR)
Lane 3 — BMI 27+ with a conditionYour starting weight/height plus prediabetes labs (A1c), or records of a past heart attack, stroke, or peripheral artery disease

Which Medicare plans count?

Eligible plan types include standalone PDPs and Medicare Advantage drug plans that are coordinated care plans — HMO, HMO-POS, local PPO, and regional PPO MA-PD plans. CMS also says people in Special Needs Plans (SNPs), employer/union group plans (EGWPs), the LI NET program, and dual Medicare-Medicaid enrollees in eligible plan types can take part.

A handful of plan types are not eligible unless you also have a standalone PDP: private fee-for-service plans, section 1876 cost plans, health care prepayment plans, PACE organizations, fallback plans, and religious fraternal benefit plans. (CMS) When in doubt, confirm your plan type before your visit so the doctor isn't guessing.

Build your documentation checklist

Get a personalized list of the exact records to gather based on your starting BMI, your conditions, and your plan type. (Self-screening only — don't enter your Medicare ID or personal health details.)

Which medications are covered — and which aren't

The Bridge covers all formulations of Foundayo, all formulations of Wegovy (the injection and the tablet), and the KwikPen form of Zepbound — for a $50 monthly copay. It does not cover the Zepbound vial or single-dose pen, and it does not cover Ozempic, Mounjaro, or any compounded GLP-1. Get the exact product right before your visit, because the wrong form bounces.
MedicationIn the Bridge?What to know
Foundayo (orforglipron)Yes — all formulationsAn oral (pill) GLP-1, FDA-approved in April 2026 for chronic weight management. An option to discuss with a clinician if avoiding injections matters to you.
Wegovy injectionYes — all formulationsFDA-approved semaglutide for weight management
Wegovy tabletYes — all formulationsThe oral Wegovy approved in late 2025
Zepbound KwikPenYes — KwikPen onlyThe KwikPen form is in
Zepbound vial / single-dose penNoThese forms are not included in the Bridge
OzempicNo (for the Bridge)Usually a diabetes drug; diabetes use may be covered under standard Part D, not the Bridge
MounjaroNo (for the Bridge)Same — diabetes use may be covered under standard Part D
Compounded semaglutide / tirzepatideNoThe Bridge is for specific FDA-approved brands only

Sources: CMS, KFF, Camino Consulting Group, Humana. CMS publishes the exact products and National Drug Codes (NDCs) on its Bridge page and may update them — check the live list to confirm your exact product.

Compounded ≠ brand-name

Compounded GLP-1s are prepared by compounding pharmacies and are not the FDA-approved products and NDCs listed for the Medicare GLP-1 Bridge. If a clinic offers you a compounded medicine and calls it a Bridge option, it isn't one. We're not knocking compounded care in general — but it cannot be filled through this program.

Same drug, different lane

Wegovy for heart-attack-and-stroke risk reduction, or Zepbound for sleep apnea, may be covered — but through standard Part D, not the Bridge. The Bridge is specifically the weight-loss lane.

How the $50 copay actually works

For an approved Bridge claim, you pay $50 a month at the pharmacy and the CMS central processor reimburses the rest. Because the Bridge sits outside your regular Part D benefit, that $50 does not count toward your deductible or your yearly out-of-pocket cap, and you can't stack manufacturer coupons or low-income subsidies on top of it. It's a flat, predictable number — which, against a $1,000-plus retail price, is the whole point.
The detailHow it works
Your copay$50 for each 30-day supply
What Medicare pays the makerA $245 net monthly price — manufacturers agreed to it (KFF)
Counts toward your deductible or out-of-pocket cap?No — the Bridge runs outside standard Part D
Manufacturer coupons?Not allowed on Bridge claims
Low-income subsidy (LIS)?Doesn't lower the $50
Where the claim goesThe CMS central processor (Humana), not your plan
The order of operations never changes: doctor submits the PA → it's approved → pharmacy fills at $50. No doctor step, no $50.

What to do before July 1, 2026

You can't push a Bridge request through before July 1, 2026 — CMS won't process them until then — but you can do everything else now so you're first in line. Confirm your plan type, gather your records, and line up a willing prescriber, so the only thing left on day one is hitting "submit." Preparation is the entire advantage here.

Right now

  • Confirm you have an eligible Part D plan (standalone PDP or eligible MA-PD)
  • Pull your starting weight and height (and your current ones)
  • Gather records for any qualifying condition (blood pressure readings and meds, kidney labs, prediabetes labs, heart or vascular history)
  • Collect your GLP-1 history — current and past meds, doses, pharmacy receipts, prescriber notes
  • Ask your current doctor: will you submit the Bridge PA after July 1?

Before you book a telehealth visit

  • Run the 7 questions above
  • Confirm state licensure and Bridge-PA support
  • Confirm the visit cost and the refund policy if they can't submit

On or after July 1, 2026

  • Your prescriber submits the PA and prescription to the CMS central processor
  • Fill at a pharmacy that can process the Bridge claim for the $50 copay
  • Keep your follow-ups, and hold onto every document in case coverage changes later

What if you're already on Ozempic, Mounjaro, or a compounded GLP-1?

Your current medication decides your next move. Ozempic and Mounjaro prescribed for diabetes may be covered under standard Part D, depending on your plan's rules — they're not Bridge weight-loss drugs. Compounded semaglutide or tirzepatide can't go through the Bridge at all. If you're already on Wegovy or Zepbound, you're closest to the Bridge lane and mostly need the right documentation.

Already on Ozempic or Mounjaro (for diabetes)

That may be covered through standard Part D, depending on your plan's formulary, prior authorization, and step-therapy rules. The Bridge is the weight-loss lane.

Already on Wegovy or Zepbound

You're in the right family. Focus on documenting your starting BMI and any qualifying condition, and confirm your prescriber will submit the Bridge PA.

Already on a compounded GLP-1

The Bridge won't fill compounded medicine. Bring your records, and ask your clinician whether moving to a covered FDA-approved brand makes sense for you. If you're switching, ask how they'd handle product choice and dosing — that's a clinical decision your prescriber makes, not us.

One safety note we won't soften

Don't stretch doses, stockpile, or switch products on your own to "bridge the gap" before July 1. Ask your prescriber for a continuity plan that covers the weeks before and after the program opens.

What if your doctor won't prescribe?

If your doctor refuses or doesn't understand the Bridge, don't argue — ask for your records, then take them to a clinician who does obesity-medicine paperwork. Your records are yours, and they're what make the next appointment fast.

Here's a message you can send your current office, word for word:

"CMS launched the Medicare GLP-1 Bridge starting July 1, 2026. My understanding is a medical provider has to submit a prior authorization and prescription for a covered medication. Can your office document my BMI at the time I started GLP-1 therapy and my qualifying conditions, and submit the Bridge PA after July 1?"

If they say no, request: your visit notes, weight and BMI history, diagnosis list, relevant labs, medication list, and any prior-authorization history. Then look for an obesity-medicine clinician or a telehealth program that handles this workflow.

Escalate to an obesity-medicine specialist when you meet (or might meet) the criteria, your doctor won't prescribe weight-loss medication, you have complex conditions, or you need an FDA-approved brand instead of compounded.

Not sure where to take your records?

We'll match you to the path most likely to find a willing prescriber for your state and situation.

Bridge, standard Part D, or cash-pay — which lane is yours?

The right lane depends on why the drug is being prescribed and whether you qualify. The Bridge is for weight-loss use when you meet the BMI criteria. Standard Part D may apply for covered uses like diabetes, heart risk, or sleep apnea. Cash-pay telehealth is the backup when Medicare won't cover your situation at all. Picking the wrong lane is the most common way people lose weeks.
Your situationLikely lane
You meet the Bridge BMI/condition criteria and want weight-loss coverageMedicare GLP-1 Bridge
You need Ozempic or Mounjaro for type 2 diabetesStandard Part D may apply
You need Wegovy for cardiovascular risk reductionStandard Part D may apply
You need Zepbound for obstructive sleep apnea with obesityStandard Part D may apply
You want a compounded GLP-1Not the Bridge
You don't qualify for the Bridge but want an FDA-approved brandCash-pay / insurance-navigation telehealth
You're honestly not sureTake the 60-second quiz →

Where our recommendations fit — and where they don't

On this page, we don't rank providers by commission, because the best Bridge answer is often a non-affiliate one — your own doctor, an obesity clinic, or a Medicare-aware telehealth program you still need to verify.

If you turn out to be in the cash-pay lane — you don't qualify for the Bridge, or you'd rather use an FDA-approved brand outside Medicare — that's where a service like Ro can genuinely help. Ro carries FDA-approved brand options and runs insurance-navigation support, and its Ro Body membership is $39 for the first month, then $149/month, or as low as $74/month with an annual plan paid upfront (medication billed separately). Just know that Ro says it currently can't coordinate GLP-1 coverage for government insurance plans — so don't expect it to run a Medicare Bridge PA. (Ro) If the Bridge is your lane, stay in it; the $50 copay beats cash-pay every time.

How we built this guide

We built this page by keeping four kinds of information in separate boxes: official CMS rules, FDA drug facts, provider-stated claims, and our own editorial judgment. We rank doctor paths by whether they can solve the Bridge problem — not by what pays us. That separation is why you can trust the parts we mark "confirmed" and stay appropriately skeptical of the parts we mark "provider-stated."

Our source order, highest authority first:

  1. 1.CMS and Medicare for the Bridge rules
  2. 2.FDA and prescribing information for drug status and safety
  3. 3.Provider websites for what each clinic says it offers (clearly labeled as claims)
  4. 4.Patient forums only to understand real fears and questions — never as proof of anything medical

What "ranking" means here: can this path actually submit the Bridge PA, is it Medicare-aware, is Bridge support confirmed or just claimed, is it available in your state, and does it keep compounded and FDA-approved clearly separate. What it does not mean: a guarantee of approval, a recommendation of any specific drug, or any endorsement by CMS, Medicare, or the FDA.

Frequently asked questions

Yes. CMS says a medical provider must submit the PA and prescription, and the provider doesn't have to be enrolled in Medicare. A telehealth clinician fits that rule as long as they're licensed to treat you and aren't on the Preclusion List.

Not for the Bridge medication itself. Whether your visit is covered or cash-pay depends on the provider, but the drug coverage doesn't hinge on it.

No. CMS won't process Bridge prior authorizations before July 1, 2026. Your doctor can prepare everything in advance, but processing begins when the Bridge opens.

All formulations of Foundayo and Wegovy (injection and tablet), and the KwikPen form of Zepbound — for a $50 monthly copay. The Zepbound vial and single-dose pen are not included.

Not for weight loss. Those are usually diabetes drugs that may be covered through standard Part D, depending on your plan — not the Bridge.

No. The Bridge covers only specific FDA-approved brand products, not compounded versions.

Likely yes. CMS judges your BMI at the time you started GLP-1 therapy, not today. Bring records that show your starting numbers.

Many MA plans with drug coverage are eligible (HMO, HMO-POS, local PPO, regional PPO). A few plan types are excluded unless you also have a standalone PDP. Confirm your plan type before your visit.

No. The Bridge runs outside standard Part D, so the $50 doesn't count toward those totals, and coupons and low-income subsidies don't apply to it.

The Bridge is temporary and currently scheduled through that date. What comes next is still uncertain, which is one more reason to get documented and enrolled while it's open.

No. Don't stretch doses, stockpile, or switch products on your own. Ask your prescriber for a safe plan.

The one that can legally treat you, prescribe a covered drug, submit the Bridge PA, and document your eligibility. Until Bridge workflows are live and confirmed, treat any provider's Bridge claim as something to verify before you pay.

Still not sure which GLP-1 program is right for you?

You don't have to figure the lane out alone. Take our free 60-second matching quiz and we'll point you to your likely path — the Bridge, standard Part D, or an FDA-approved option — plus the records to gather and the questions to ask before you book. No commitment, and you'll have a clear next step in about a minute. (Self-screening only — please don't enter your Medicare ID or personal health details.)

Take our free 60-second matching quiz →

Sources

  1. CMS — Medicare GLP-1 Bridge
  2. KFF — What to Know About the BALANCE Model and the Medicare GLP-1 Bridge
  3. Humana — Does Medicare Cover GLP-1 Weight Loss Drugs?
  4. Camino Consulting Group — Medicare GLP-1 Coverage 2026 Provider Guide
  5. FDA — Foundayo (orforglipron) approval announcement
  6. Foundayo Prescribing Information (Eli Lilly)
  7. Wegovy Prescribing Information
  8. Form Health — FAQs (Medicare/FDA-approved medication statements)
  9. Eli Lilly — Telehealth for Obesity (knownwell Medicare listing)
  10. Shapely — Medicare coverage page
  11. Ro — Weight Loss Program Pricing

By the Weight Loss Provider Guide editorial team. Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We reviewed CMS, Medicare, FDA, and provider-published information and separated official rules from provider claims and unverified workflows. This page is informational and is not medical advice; decisions about GLP-1 medications are clinical decisions made between you and your prescriber. These medications carry warnings, including a boxed warning related to thyroid C-cell tumors and contraindications for people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) — talk to your doctor and read the prescribing information.

Last verified: . Next scheduled verification: June 2026, or sooner if CMS updates Bridge guidance.